Management of patent foramen ovale in patients with cryptogenic stroke: Is device closure superior to medical treatment? A brief review

摘要

Background:Recent randomized controlled trial (RCTs) comparing percutaneous closure with antithrombotic treatment in patients with patent foramen ovale (PFO) and cryptogenic stroke revealed inconsistent results. Indeed, there is still no consensus on the management of these patients, namely closure or medical therapy treatment.